Search results for "pathogen"

showing 10 items of 1657 documents

Mining virulence genes using metagenomics.

2011

When a bacterial genome is compared to the metagenome of an environment it inhabits, most genes recruit at high sequence identity. In free-living bacteria (for instance marine bacteria compared against the ocean metagenome) certain genomic regions are totally absent in recruitment plots, representing therefore genes unique to individual bacterial isolates. We show that these Metagenomic Islands (MIs) are also visible in bacteria living in human hosts when their genomes are compared to sequences from the human microbiome, despite the compartmentalized structure of human-related environments such as the gut. From an applied point of view, MIs of human pathogens (e.g. those identified in enter…

ScienceVirulenceBacterial genome sizeBiologyGenomeMicrobiologyMicrobiologyMicrobiomeBiologyGenome EvolutionComparative genomicsGeneticsEscherichia ColiMultidisciplinaryBacteriaVirulenceQHuman microbiomeRGenomicsPathogenicity islandBacterial PathogensMetagenomicsMicrobial EvolutionMedicineMetagenomicsGenome BacterialResearch ArticlePLoS ONE
researchProduct

Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians.

1997

In the present study we have investigated the prevalence of organ-specific and non organ-specific autoantibodies in 26 healthy centenarians (6 men, 20 women; age range 101-106 years), using as controls 54 healthy old (33 men and 21 women, age range 71-93) and 56 young subjects (29 men and 27 women, age range 26-60). We assayed sera of each group for the following organ-specific autoantibodies, anti-gastric mucosa (anti-PCA), anti-thyroglobulin (anti-Tg) and non organ-specific autoantibodies, anti-cardiolipin (anti-APA IgG and IgM), anti-nuclear antigens (anti-ANA), anti-double strand DNA (anti-ds-DNA), anti-extractable nuclear antigens (anti-ENA). Finally, natural anti-alpha-galactosyl (ant…

SenescenceAdultMaleAgingCardiolipinsmedicine.disease_causeThyroglobulinAutoimmunityPathogenesisAntigenOrgan specificmedicineHumansAgedAutoantibodiesAged 80 and overbiologybusiness.industryAutoantibodyNuclear ProteinsAntigens NuclearDNAMiddle AgedImmunologybiology.proteinFemaleAntibodybusinessDevelopmental BiologyMechanisms of ageing and development
researchProduct

Hsp60 and human aging: Les liaisons dangereuses 

2013

Stressors can cause abnormal intracellular accumulation of Hsp60 and its localization in extramitochondrial sites, secretion, and circulation, with immune system activation. Dysfunction of chaperones associated with their quantitative and qualitative decline with aging (chaperonopathies of aging) characterizes senescence and is a potential causal factor in the physiological deterioration that occurs with it. The role of Hsp60 in aging is not easy to elucidate, because aging is accompanied by pathologies (e.g., cardiovascular and neurodegenerative disorders, osteoporosis, diabetes, cancer, etc.) in which Hsp60 has been implicated but, although those disorders are more frequent in the elderly…

SenescenceAginganimal structuresOsteoporosischemical and pharmacologic phenomenaInflammationDiseaseBiologycomplex mixturesMitochondrial ProteinsPathogenesisImmune systemDiabetes mellitusmedicineHumansCellular SenescenceAutoantibodiesHeart FailurefungiHSP 60 AGING CHAPERONES.Neurodegenerative DiseasesChaperonin 60Atherosclerosismedicine.diseaseMitochondriaImmune SystemImmunologyHSP60Arthropathy Neurogenicmedicine.symptomFrontiers in Bioscience
researchProduct

Hsp60 and Hsp10 in Ageing

2009

HSP and molecular chaperones, both referred to in this chapter as chaperones, are key players in development and senescence. With regard to senescence, several issues are critical: the role of normal chaperones in the process of ageing itself and in preventing and controlling age-associated diseases, the role of defective chaperones (chaperonopathies) in the onset and progression of senescence and in the etiology of old-age diseases, the interaction of chaperones with the immune system, and the potential of chaperones as therapeutic agents for counteracting the deleterious effects of ageing on molecules and cells and for treating proteinopathies of the elderly (chaperonotherapy). All these …

Senescencebiologybusiness.industryDiseaseBioinformaticsChaperoninPathogenesisImmune systemAgeingChaperone (protein)biology.proteinMedicinebusinessPathological
researchProduct

Potentially human-virulent Vibrio vulnificus isolates from diseased great pompano (Trachinotus goodei).

2019

Vibrio vulnificus is an opportunistic human pathogen responsible for the majority of seafood-associated deaths worldwide and is also a relevant fish pathogen for the aquaculture industry. In addition to infections in aquatic livestock, V. vulnificus also represents a risk to aquarium animals. For the first time, this work describes an important mortality outbreak in Trachinotus goodei in a zoo aquarium, with the isolation of Vibrio vulnificus (Vv) from the internal organs of the diseased fish. The isolates were identified by MALDI-TOF MS, serotyped and characterized by pulsed-field gel electrophoresis (PFGE). Although the isolates from great pompanos did not belong to pathovar piscis (forme…

Serotype040301 veterinary sciencesVirulenceHuman pathogenVibrio vulnificusAquacultureMicrobiologyDisease Outbreaks0403 veterinary science03 medical and health sciencesFish DiseasesPulsed-field gel electrophoresisAnimalsHumansPathogenVibrio vulnificus030304 developmental biology0303 health sciencesGeneral VeterinaryGeneral Immunology and MicrobiologybiologyVirulence04 agricultural and veterinary sciencesGeneral Medicinebiology.organism_classificationVibrioPerciformesPathovarSpainVibrio InfectionsTransboundary and emerging diseases
researchProduct

Frequency of exposure of endangered Caspian seals to Canine distemper virus, Leptospira interrogans, and Toxoplasma gondii

2017

Canine distemper virus (CDV), Leptospira interrogans, and Toxoplasma gondii are potentially lethal pathogens associated with decline in marine mammal populations. The Caspian Sea is home for the endangered Caspian seal (Pusa caspica). In the late 1990s and early 2000s, CDV caused a series of mortality events involving at least several thousand Caspian seals. To assess current infection status in Caspian seals, we surveyed for antibodies to three pathogens with potential to cause mortality in marine mammals. During 2015-2017, we tested serum samples from 36, apparently healthy, Caspian seals, accidentally caught in fishing nets in the Caspian Sea off Northern Iran, for antibodies to CDV, L. …

SerotypeAgingVeterinary medicineSeals EarlessPhysiologyanimal diseaseslcsh:MedicineAntibodies ProtozoanMarine and Aquatic SciencesAntibodies ViralPathology and Laboratory MedicineBiochemistryToxoplasma Gondii0403 veterinary science0302 clinical medicineImmune PhysiologyMedicine and Health Scienceslcsh:ScienceDistemper Virus CanineMammalsLeptospiraProtozoanseducation.field_of_studySealsImmune System ProteinsMultidisciplinarybiologyEukaryota04 agricultural and veterinary sciencesAntibodies BacterialLeptospirosisBacterial PathogensLeptospira InterrogansMedical MicrobiologyVertebratesPathogensToxoplasmaLeptospira interrogansResearch Article040301 veterinary sciencesImmunology030231 tropical medicinePopulationMarine BiologyMicrobiologyAntibodies03 medical and health sciencesDogsLeptospiraparasitic diseasesmedicineAnimalsLeptospirosisDistemperMarine MammalseducationMicrobial PathogensPusaBacteriaCanine distemperlcsh:ROrganismsBiology and Life SciencesProteinsToxoplasma gondiibiology.organism_classificationmedicine.diseaseParasitic ProtozoansToxoplasmosis AnimalAmniotesEarth Scienceslcsh:QPLOS ONE
researchProduct

The kinetics of antibody production in mucus and serum of European eel (Anguilla anguilla L.) after vaccination against Vibrio vulnificus: developmen…

2003

Abstract Vibrio vulnificus serovar E, a bacterial pathogen for eels cultured in intensive systems, is transmitted through water and enters into new hosts mainly via gills. The main objective of this work was to study the kinetics of antibody production to V. vulnificus in serum and mucus and their relationship with protection after vaccination. To quantify local mucus antibodies, a new ‘in situ’ dot blot immunoassay using image analysis has been developed. This assay was applied to measure antibody production in the skin zone next to the gills. We found that (i) the immune response in mucus was faster (peak at days 3–4) and shorter in duration (titres significantly elevated up to day 5 and …

SerotypeGillanimal structuresImmunoblottingDot blotEnzyme-Linked Immunosorbent AssayVibrio vulnificusAquatic ScienceMicrobiologyFish DiseasesImmune systemImage Processing Computer-AssistedAnimalsEnvironmental ChemistryVibrio vulnificusPathogenSkinbiologyVaccinationGeneral MedicineAnguillabiology.organism_classificationAntibodies BacterialMucusKineticsMucusVibrio InfectionsBacterial Vaccinesbiology.proteinAntibodyFish & Shellfish Immunology
researchProduct

Immunogenic antigens of the eel pathogen Vibrio vulnificus serovar E.

2003

Abstract The immunogenic antigens of Vibrio vulnificus serovar E were investigated in the eel. Fish were vaccinated by immersion with Vulnivaccine (V), revaccinated 2 years later by intraperitoneal injection (RV) and bath infected 15 days post-revaccination (RVI). The specific immune response in serum was followed in all groups, and selected sera were used for immunostaining of surface (SA) and extracellular antigens (ECA). Bacteria were grown in iron-rich (TSB and MSWYE) and iron-poor media (TSB and MSWYE plus human transferrin (TSB-T and MSWYE-T)) as well as eel serum (ES), and their SA and ECA were extracted and electrophoretically analysed. Cells grown in MSWYE-T and ES presented the sa…

SerotypeLipopolysaccharidesTime FactorsLipopolysaccharideIronImmunoblottingEnzyme-Linked Immunosorbent AssayVibrio vulnificusAquatic ScienceMicrobiologychemistry.chemical_compoundAntigenEnvironmental ChemistryAnimalsPathogenVibrio vulnificuschemistry.chemical_classificationAntigens BacterialbiologyImmune SeraGeneral Medicinebiology.organism_classificationAnguillachemistryTransferrinAntibody FormationBacterial VaccinesElectrophoresis Polyacrylamide GelBacterial outer membraneBacteriaBacterial Outer Membrane ProteinsFishshellfish immunology
researchProduct

First description of non-motile Yersinia ruckeri serovar I strains causing disease in rainbow trout, Oncorhynchus mykiss (Walbaum), cultured in Spain.

2006

Yersinia ruckeri, the causal agent of enteric redmouth (ERM) disease, was isolated from epizootics that occurred in different Spanish rainbow trout, Oncorhynchus mykiss (Walbaum), farms in which vaccination against ERM had been performed. In all episodes, the most pronounced clinical signs exhibited by affected fish were severe haemorrhages in the mouth, eyes and around the vent. The isolates were identified as Y. ruckeri serovar I by 16S rRNA sequencing together with serological tests. They lacked motility and lipase activity and thus belonged to biotype 2, and were highly virulent for juvenile rainbow trout, both by intraperitoneal injection (from 3.1 x 10(2) to 6.3 x 10(3) cfu per fish) …

SerotypeLipopolysaccharidesYersinia InfectionsVeterinary (miscellaneous)FisheriesVirulenceAquatic ScienceCommunicable Diseases EmergingPolymerase Chain ReactionMicrobiologyFish DiseasesAquacultureAgglutination TestsRNA Ribosomal 16SAnimalsSerologic TestsPathogenDNA PrimersbiologyVirulencebusiness.industryEnteric redmouth diseaseO Antigensbiology.organism_classificationAntibodies BacterialYersiniaTroutSpainOncorhynchus mykissRainbow troutYersinia ruckeribusinessJournal of fish diseases
researchProduct

Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla

2001

Vibriosis due to Vibrio vulnificus serovar E (biotype 2) is one of the main causes of mortality in European eels cultured in Europe. The main objective of this study was to develop a vaccine and a vaccination procedure against this pathogen. With this aim, we tested several vaccine formulations (inactivated whole-cells with and without toxoids‹inactivated extracellular products‹from capsulated and uncapsulated strains, attenuated live vaccines and purified lipopolysaccharide [LPS]) on eels maintained under controlled laboratory conditions using different delivery routes (injection and immersion). To study the immune response we estimated antibody titers and bactericidal/bacteriostatic activ…

SerotypeQuality ControlVibrio vulnificus serovar E ; Vibrio vulnificus biotype 2 ; Eel vaccines ; Vibrio vaccines ; Vaccination by injection ; Vaccination by prolonged immersionImmunization SecondaryVibrio vulnificus biotype 2Eel vaccinesVibrio vulnificusAquacultureAquatic ScienceBiologyAntibodies Viral:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyFish DiseasesVaccination by injectionAntigenVibrionaceaeImmunityAntibody SpecificityUNESCO::CIENCIAS DE LA VIDAAnimalsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología)Vibrio vaccinesPathogenEcology Evolution Behavior and SystematicsVaccination by prolonged immersionSkinVibrio:CIENCIAS DE LA VIDA::Biología animal (Zoología) [UNESCO]VaccinationAntibody titerbiology.organism_classificationAnguillaVirologyVaccinationEuropeVibrio vulnificus serovar EVibrio InfectionsBacterial Vaccines
researchProduct